SBIR-STTR Award

MYH 2.0: a Digital Experience to Improve Survivorship Among AYA Cancer Survivors
Award last edited on: 6/17/2022

Sponsored Program
SBIR
Awarding Agency
NIH : NCI
Total Award Amount
$251,762
Award Phase
1
Solicitation Topic Code
424
Principal Investigator
Jeffery Mclaughlin

Company Information

Radiant Creative Group LLC

2200 North Loop West Suite 180
Houston, TX 77018
   (832) 618-1070
   info@radiantexp.com
   www.radiantexp.com
Location: Single
Congr. District: 18
County: Harris

Phase I

Contract Number: 75N91021C00053
Start Date: 9/16/2021    Completed: 6/15/2022
Phase I year
2021
Phase I Amount
$251,762
Adolescent and Young Adult (AYA) cancer survivors are expected to assume primary responsibility for their healthcare when they reach adulthood. However, only a minority (lt18%) of adult childhood cancer survivors obtain risk-based follow-up care. Transition readiness is a critical precursor to adult self-management of care, and adult self-management improves health status and reduces healthcare utilization. A growing body of research in other populations has generally shown positive associations between transition readiness and adherence to adult care and better health outcomes. While there is strong evidence demonstrating that the transition to adult-oriented healthcare is critical, there are few formal transition programs available, and no theoretically driven survivor-focused interventions. In this project, we will adapt and extend a prototype digital health intervention, Managing Your Health (MYH), that features guided peer mentor interaction with tailored expert content that addresses survivor-related barriers to transition readiness including inadequate knowledge of cancer treatment and late effect risks, lack of self-management skills, low self-efficacy for managing care, concern about impersonal relationships with adult providers, poor communication with parents and providers, and lower perceived priority of health compared with competing developmental pursuits. Informed by a cohort of key stakeholders and representative users, we will develop the next generation of the intervention of MYH and evaluate it for usability and feasibility among a sample of pediatric cancer survivors.

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
----